InVivo Therapeutics

+$0.16 (+3.88%) Today
-$0.04 (-1.08%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NVIV and other ETFs, options, and stocks.

About NVIV

Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord.

CEO
Richard Toselli
Employees
7
Headquarters
Cambridge, Massachusetts
Founded
2005

NVIV Key Statistics

Market cap
5.78M
Price-Earnings ratio
—
Dividend yield
—
Average volume
10.33K
High today
$4.40
Low today
$3.99
Open price
$3.99
Volume
7.13K
52 Week high
$23.19
52 Week low
$3.50

NVIV Earnings

-$1.94
-$1.06
-$0.19
$0.69
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure